Cited by 32Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesCardiac Health and Mental HealthCOVID-19 and Mental Health

Benzodiazepines and anxiety sensitivity in panic disorder

Fava, Giovanni A., Grandi, Silvana, Belluardo, Piera, Savron, Gianni, Raffi, Anna R., Conti, Sandra, Saviotti, Francesco M.·1994·Progress in Neuro-Psychopharmacology and Biological Psychiatry

Abstract

1. Benzodiazepines were discontinued in 16 patients who had recovered from panic disorder with agoraphobia after exposure treatment. 2. Drug discontinuation yielded a significant decrease in anxiety sensitivity and state anxiety in these long-term users. 3. Several likely explanations for the findings are discussed. 4. In the short term, treatment of panic disorder with benzodiazepines may lower anxiety symptoms. However, in the long run, it may decrease the individual tolerance to anxiety and discomfort.

Integrity signals

Registry

Crossref · 10.1016/0278-5846(94)90118-x

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Fava, G. A., Grandi, S., Belluardo, P., Savron, G., Raffi, A. R., Conti, S., & Saviotti, F. M.
Affiliations
  • University at Buffalo, State University of New York (US)
  • University of Bologna (IT)
Venue
Progress in Neuro-Psychopharmacology and Biological Psychiatry
Publisher
Elsevier BV
Published
1994-11
Volume
18
Issue
7
Pages
1163-1168
ISSN
0278-5846 (ISSN-L)
OpenAlex
W2071908356
Cited by
32
References
15
Citations by year
2024: 1 · 2023: 1 · 2022: 1 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 1 · 2013: 2 · 2012: 1
FWCI
3.17
Type
journal article
Language
en
Open access
closed
Locations
  • Progress in Neuro-Psychopharmacology and Biological Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
  • Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
Keywords
benzodiazepines, anxiety sensitivity, panic disorder, agoraphobia, benzodiazepine discontinuation, state anxiety, exposure therapy, long-term benzodiazepine use
MeSH terms
Adult, Agoraphobia, Anxiety, Benzodiazepines, Female, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Substance Withdrawal Syndrome, Anti-Anxiety Agents, Panic Disorder

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review